Pharmaceuticals (May 2023)

Vitamin D and Osteogenesis Imperfecta in Pediatrics

  • Francesco Coccia,
  • Angelo Pietrobelli,
  • Thomas Zoller,
  • Alessandra Guzzo,
  • Paolo Cavarzere,
  • Angelo Fassio,
  • Carl-Erik Flodmark,
  • Davide Gatti,
  • Franco Antoniazzi

DOI
https://doi.org/10.3390/ph16050690
Journal volume & issue
Vol. 16, no. 5
p. 690

Abstract

Read online

Osteogenesis Imperfecta (OI) is a heterogeneous group of inherited skeletal dysplasias characterized by bone fragility. The study of bone metabolism, in these disease, is problematic in terms of clinical and genetic variability. The aims of our study were to evaluate the importance of Vitamin D levels in OI bone metabolism, reviewing studies performed on this topic and providing advice reflecting our experience using vitamin D supplementation. A comprehensive review on all English-language articles was conducted in order to analyze the influence of vitamin D in OI bone metabolism in pediatric patients. Reviewing the studies, contradictory data were found on the relationship between 25OH vitamin D levels and bone parameters in OI, and in several studies the baseline levels of 25OH D were below the threshold value of 75 nmol/L. In conclusion, according to the literature and to our experience, we highlight the importance of adequate vitamin D supplementation in children with OI.

Keywords